|
DE3485094D1
(de)
|
1983-01-25 |
1991-10-31 |
Ciba Geigy Ag |
Neue peptidderivate.
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
CA1324969C
(en)
|
1988-05-06 |
1993-12-07 |
Jeffrey R. Shuster |
High level expression of proteins in yeast
|
|
NZ241926A
(en)
|
1988-08-25 |
1993-08-26 |
Liposome Co Inc |
Immunisation dosage form comprising a salt of an organic acid derivative of a sterol and an antigen
|
|
US6572862B1
(en)
|
1989-11-08 |
2003-06-03 |
Baylor College Of Medicine |
Methods and reagents to detect and characterize Norwalk and related viruses
|
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
|
US5340740A
(en)
|
1992-05-15 |
1994-08-23 |
North Carolina State University |
Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
|
|
DK0671948T3
(da)
|
1992-06-25 |
1997-09-01 |
Smithkline Beecham Biolog |
Vaccinepræparat indeholdende adjuvanser
|
|
WO1994005700A2
(en)
|
1992-09-07 |
1994-03-17 |
Baylor College Of Medicine |
Methods and reagents to detect and characterize norwalk and related viruses
|
|
ATE157882T1
(de)
|
1993-03-23 |
1997-09-15 |
Smithkline Beecham Biolog |
3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
|
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
FR2726003B1
(fr)
|
1994-10-21 |
2002-10-18 |
Agronomique Inst Nat Rech |
Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
|
ES2298316T3
(es)
|
1997-09-05 |
2008-05-16 |
Glaxosmithkline Biologicals S.A. |
Emulsiones de aceite en agua que contienen saponinas.
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
NZ504894A
(en)
|
1997-12-02 |
2002-12-20 |
Powderject Vaccines Inc |
Crystalline vaccine and adjuvant compositions jointly and separately administered to animals using a transdermal or transmucosally delivery technique
|
|
FR2771751B1
(fr)
|
1997-12-03 |
2000-05-26 |
Assist Publ Hopitaux De Paris |
Erythrovirus et ses applications
|
|
IL137809A0
(en)
|
1998-02-12 |
2001-10-31 |
American Cyanamid Co |
Pneumococcal and meningococcal vaccines formulated with interleukin-12
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
IL138000A0
(en)
|
1998-04-09 |
2001-10-31 |
Smithkline Beecham Biolog |
Adjuvant compositions
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
DE69935606T9
(de)
|
1998-10-16 |
2021-03-11 |
Glaxosmithkline Biologicals S.A. |
Adjuvanzsysteme und impfstoffe
|
|
ES2340230T3
(es)
|
1998-11-10 |
2010-05-31 |
University Of North Carolina At Chapel Hill |
Vectores viricos y sus procedimientos de preparacion y administracion.
|
|
ES2398413T3
(es)
|
1999-06-22 |
2013-03-19 |
Japan As Represented By Director-General Of National Institute Of Infectious Diseases |
Kit de detección de SRSV
|
|
KR20020048942A
(ko)
|
1999-09-24 |
2002-06-24 |
장 스테판느 |
폴리옥시에틸렌 알킬 에테르 또는 에스테르 및 하나이상의 비이온성 계면활성제를 포함하는 애쥬번트
|
|
CZ20021043A3
(cs)
|
1999-09-24 |
2002-08-14 |
Smithkline Beecham Biologicals S. A. |
Pouľití kombinace polyoxyethylensorbitanového esteru a oktoxynolu pro výrobu pomocného prostředku
|
|
EP1311288A1
(en)
|
2000-01-20 |
2003-05-21 |
Ottawa Health Research Institute |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
|
NZ522840A
(en)
|
2000-06-01 |
2004-12-24 |
Univ North Carolina |
A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together
|
|
DK1354204T4
(da)
|
2000-06-15 |
2010-06-14 |
Novartis Vaccines & Diagnostic |
HCV-antigen/antistof-kombinationssay
|
|
JP2002020399A
(ja)
|
2000-07-10 |
2002-01-23 |
Osaka Prefecture |
ノルウォークウイルス（ｎｖ）を認識するモノクローナル抗体
|
|
AU9475001A
(en)
|
2000-09-26 |
2002-04-08 |
Hybridon Inc |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
|
ES2310201T3
(es)
|
2001-02-13 |
2009-01-01 |
Government Of The United States Of America, As Represented By The Secretary Of The Army |
Vacuna para inmunizacion transcutanea contra la diarrea de los viajeros.
|
|
JP2004529906A
(ja)
|
2001-03-19 |
2004-09-30 |
イオマイ コーポレイシヨン |
経皮的免疫賦活
|
|
GB0123580D0
(en)
|
2001-10-01 |
2001-11-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
GB0123756D0
(en)
|
2001-10-03 |
2001-11-21 |
King S College London |
A novel chaperone-type of adjuvant for vaccination - Basic 1
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
FR2832423B1
(fr)
|
2001-11-22 |
2004-10-08 |
Vivalis |
Systeme d'expression de proteines exogenes dans un systeme aviaire
|
|
US20050175588A1
(en)
|
2002-02-11 |
2005-08-11 |
Mosca Joseph D. |
Production of a protein delivery system for in vivo therapeutic treatment
|
|
FR2836924B1
(fr)
|
2002-03-08 |
2005-01-14 |
Vivalis |
Lignees de cellules aviaires utiles pour la production de substances d'interet
|
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
|
WO2005032457A2
(en)
|
2003-07-21 |
2005-04-14 |
Boyce Thompson Institute For Plant Research, Inc. |
Vectors and methods for immunization against norwalk virus using transgenic plants
|
|
EP1500699A1
(en)
|
2003-07-22 |
2005-01-26 |
Vivalis |
Production of vaccinia virus with adherent or non adherent avian cell lines
|
|
US7902338B2
(en)
|
2003-07-31 |
2011-03-08 |
Immunomedics, Inc. |
Anti-CD19 antibodies
|
|
EP1670824A2
(en)
|
2003-09-24 |
2006-06-21 |
Montana State University |
Norovirus monoclonal antibodies and peptides
|
|
EP1528101A1
(en)
|
2003-11-03 |
2005-05-04 |
ProBioGen AG |
Immortalized avian cell lines for virus production
|
|
US8435517B2
(en)
|
2008-09-17 |
2013-05-07 |
Xencor, Inc. |
Compositions and methods for treating IgE-mediated disorders
|
|
EP1751289B1
(en)
|
2004-05-18 |
2009-01-14 |
Alphavax, Inc. |
Tc-83-derived alphavirus vectors, particles and methods
|
|
US7691368B2
(en)
|
2005-04-15 |
2010-04-06 |
Merial Limited |
Vaccine formulations
|
|
WO2007053188A2
(en)
|
2005-06-01 |
2007-05-10 |
Dow Global Technologies, Inc. |
Production of multivalent virus like particles
|
|
CA2630220C
(en)
*
|
2005-11-22 |
2020-10-13 |
Doris Coit |
Norovirus and sapovirus antigens
|
|
WO2008016391A2
(en)
|
2006-01-31 |
2008-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
|
US20100203083A1
(en)
|
2007-05-31 |
2010-08-12 |
Medigene Ag |
Mutated structural protein of a parvovirus
|
|
JP2010539192A
(ja)
*
|
2007-09-18 |
2010-12-16 |
リゴサイト ファーマスーティカルズ，インコーポレイテッド |
ノロウイルスに対して防御免疫応答を付与する方法
|
|
CN101153341B
(zh)
*
|
2007-09-21 |
2010-12-15 |
珠海市疾病预防控制中心 |
诺如病毒gⅱ型检测用引物、检测方法、检测试剂盒
|
|
PT2268618E
(pt)
|
2008-03-03 |
2015-10-12 |
Novartis Ag |
Compostos e composições moduladores da actividade tlr
|
|
WO2010006238A2
(en)
|
2008-07-11 |
2010-01-14 |
The Administrators Of The Tulane Educational Fund |
Stimulus-responsive apta-chelamers
|
|
AU2009279456B2
(en)
*
|
2008-08-08 |
2015-02-05 |
Takeda Vaccines, Inc. |
Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
|
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
|
|
SG10201703067QA
(en)
|
2008-11-26 |
2017-05-30 |
Amgen Inc |
Variants Of Activin IIB Receptor Polypeptides And Uses Thereof
|